Predictive value on advance Hodgkin Lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.

Alberto BiggiStephane ChauvieFederico FallancaLuca GuerraFabrizio BergesioMassimo MengaAndrea BianchiMichele GregianinAgostino ChiaravallotiOrazio SchillaciChiara PavoniCaterina PattiMarco PicardiAlessandra RomanoCorrado SchiavottoRoberto SorasioSimonetta VivianiGiorgio La NasaFrancesco AngotziAlessandro RambaldiAndrea Gallamini

Published in: Hematological oncology (2022)

The present study demonstrates that eotPET is an accurate tool to predict treatment outcome in HL and confirms the appropriateness of the Lugano classification for eotPET evaluation. This article is protected by copyright. All rights reserved.

Keyphrases

hodgkin lymphoma
clinical trial
machine learning
deep learning
high resolution
study protocol
phase ii
double blind
clinical evaluation
placebo controlled